Interferon-associated retinopathy.

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol (2003) 2.20

Interferon associated retinopathy. Br J Ophthalmol (1998) 1.65

Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol (2007) 1.46

Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol (2004) 1.37

New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle (2008) 1.35

Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol (1995) 1.26

Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol (2006) 1.12

Clinical experience with interferon alfa-2a for exudative age-related macular degeneration. Br J Ophthalmol (1993) 1.08

Pegylated interferon alpha-associated optic neuropathy. J Neuroophthalmol (2010) 1.06

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol (1998) 0.97

Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. Jpn J Ophthalmol (2009) 0.92

Severe interferon associated retinopathy. Br J Ophthalmol (2003) 0.92

Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. World J Gastroenterol (2006) 0.92

Development of neovascular glaucoma in the course of interferon alfa therapy for hepatitis type C. Br J Ophthalmol (1994) 0.90

Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report. World J Gastroenterol (2012) 0.83

Ocular side effects of biological agents in oncology: what should the clinician be aware of? Onco Targets Ther (2013) 0.82

Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World J Gastroenterol (2013) 0.81

Severe course of cutaneous melanoma associated paraneoplastic retinopathy. Br J Ophthalmol (1995) 0.81

Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.81

The effect of low-dose interferon treatment on visual evoked potentials. Doc Ophthalmol (1998) 0.79

Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels. Clin Exp Immunol (2010) 0.79

Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature. J Neurol (2015) 0.77

[Combined retinal artery and vein occlusions associated with interferon beta therapy]. Ophthalmologe (2012) 0.77

Ocular side effects of anti-rheumatic medications: what a rheumatologist should know. Lupus (2010) 0.76

Symptomatic interferon retinopathy successfully treated by hypertension management. Br J Ophthalmol (2007) 0.76

Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C. World J Gastroenterol (2014) 0.75

Retinopathy associated with adjuvant high-dose interferon-α2b in a patient with resected melanoma: a case report and review of the literature. Oncologist (2012) 0.75

Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation. Br J Ophthalmol (1994) 0.75

Retinopathy associated with interferon therapy in patients with hepatitis C virus. Clin Ophthalmol (2012) 0.75

Distant cancer effects on standardised testing of peripheral vision. Br J Ophthalmol (2001) 0.75

Managing patients on interferon therapy. Dig Dis Sci (1996) 0.75

Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol (2016) 0.75

[Anterior ischemic optic neuropathy and retinopathy during systemic interferon therapy]. Ophthalmologe (2007) 0.75

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.92

National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med (1983) 6.67

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol (1994) 5.76

HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43

Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med (1982) 4.98

A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology (1991) 4.83

Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res (1996) 4.75

Risk factors for Kaposi's sarcoma in homosexual men. Lancet (1982) 4.70

High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A (2001) 4.31

Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem (1997) 3.50

Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol (1994) 3.44

Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA (1994) 3.41

Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol (1999) 3.13

Fluorescein angiography complication survey. Ophthalmology (1986) 2.96

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95

Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc Natl Acad Sci U S A (1983) 2.92

Equatorius: a new hominoid genus from the Middle Miocene of Kenya. Science (1999) 2.92

Digital indocyanine green videoangiography and choroidal neovascularization. Retina (1992) 2.86

External beam radiation therapy for choroidal neovascularization. Ophthalmology (1998) 2.84

HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health (2000) 2.74

Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma. Am J Med (1982) 2.71

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69

Infraslow oscillations modulate excitability and interictal epileptic activity in the human cortex during sleep. Proc Natl Acad Sci U S A (2004) 2.69

Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina (1995) 2.65

Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology (1998) 2.62

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS (1998) 2.53

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology (1996) 2.41

Response of the Peritoneal Tissue to Dusts Introduced as Foreign Bodies. Am J Public Health Nations Health (1935) 2.37

Adverse reactions due to indocyanine green. Ophthalmology (1994) 2.30

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health (1998) 2.28

Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol (1999) 2.27

Central serous chorioretinopathy in younger and older adults. Ophthalmology (1996) 2.26

Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr (2000) 2.22

A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science (1988) 2.20

Type-A behavior and central serous chorioretinopathy. Retina (1987) 2.12

Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology (2000) 2.09

Purification, primary structure, and immunological characterization of the 26-kDa calsequestrin binding protein (junctin) from cardiac junctional sarcoplasmic reticulum. J Biol Chem (1995) 2.08

Self-destructing (non-reusable) syringes. Lancet (1991) 2.04

Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust (1989) 2.02

Removal of aspirated foreign bodies by inhalation and postural drainage. A survey of 24 cases. Clin Pediatr (Phila) (1973) 1.93

An ultramicro method of amino acid analysis: application to studies of protein metabolism in cultured cells. Anal Biochem (1979) 1.89

The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology (1995) 1.85

CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS (1991) 1.85

Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res (1999) 1.85

Possible female-to-female transmission of human immunodeficiency virus. Ann Intern Med (1986) 1.82

Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci (1997) 1.81

Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology (1984) 1.75

Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr (1997) 1.75

Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend (1999) 1.74

Transient global amnesia: clinical characteristics and prognosis. Neurology (1987) 1.72

The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. J Subst Abuse Treat (1984) 1.70

Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A (1997) 1.66

Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina (1996) 1.65

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol (1996) 1.64

Chemotaxis to aromatic and hydroaromatic acids: comparison of Bradyrhizobium japonicum and Rhizobium trifolii. J Bacteriol (1985) 1.63

Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc (1986) 1.62

Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res (1991) 1.60

Properties of an inducible uptake system for beta-ketoadipate in Pseudomonas putida. J Bacteriol (1976) 1.60

The ocular complications of boxing. Ophthalmology (1987) 1.60

Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS (1987) 1.60

Very slow EEG responses lateralize temporal lobe seizures: an evaluation of non-invasive DC-EEG. Neurology (2003) 1.59

Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology (2000) 1.55

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis (2000) 1.54

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53

Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology (1991) 1.52

Appendices epiploicae of the colon: radiologic and pathologic features. Radiographics (1992) 1.51

Progressive outer retinal necrosis presenting with isolated optic neuropathy. Neurology (2004) 1.50

Ocular Whipple's disease: earlier definitive diagnosis. Ophthalmology (2001) 1.50

Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study. Ann Intern Med (1984) 1.50

The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr (1992) 1.50

Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology (1991) 1.50

Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration. Br J Ophthalmol (2008) 1.49

The expanding clinical spectrum of unilateral acute idiopathic maculopathy. Arch Ophthalmol (1996) 1.48

Retinal prosthesis: an encouraging first decade with major challenges ahead. Ophthalmology (2001) 1.48

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1978) 1.47

Constitutive synthesis of enzymes of the protocatechuate pathway and of the beta-ketoadipate uptake system in mutant strains of Pseudomonas putida. J Bacteriol (1976) 1.47

Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology (1998) 1.46

Heat wave mortality in New York City, 1949 to 1970. Arch Environ Health (1975) 1.46

A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmology (1991) 1.45

Indocyanine green-guided laser photocoagulation of focal spots at the edge of plaques of choroidal neovascularization. Arch Ophthalmol (1996) 1.44

Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci (1999) 1.44

Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology (1993) 1.43

High prevalence of low serum vitamin B12 in a multi-ethnic Israeli population. Br J Haematol (2001) 1.43

Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci (2000) 1.43

Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J Nutr (1994) 1.42

Cilioretinal artery occlusion in young adults with central retinal vein occlusion. Ophthalmology (1991) 1.42

Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med (1982) 1.41

Three cell wall mannoproteins facilitate the uptake of iron in Saccharomyces cerevisiae. J Biol Chem (2001) 1.40

A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Data revisited. Arch Ophthalmol (1994) 1.39

Diagnosis of pneumonia due to Pneumocystis by subsegmental pulmonary lavage via the fiberoptic bronchoscope. Chest (1978) 1.37

Enzymes of the beta-ketoadipate pathway are inducible in Rhizobium and Agrobacterium spp. and constitutive in Bradyrhizobium spp. J Bacteriol (1986) 1.36